ANATOMICAL THERAPEUTIC CHEMICAL (ATC) CLASSIFICATION SYSTEM |
|||||||||||||||
[WHO Collaborating Centre for Drug Statistics Methodology (WHOCC)] |
|||||||||||||||
|
|
|||||||||||||||
|
|
C |
|
|||||||||||||
|
|
|||||||||||||||
| C | CARDIOVASCULAR SYSTEM | Show WHO |
| C01 | CARDIAC THERAPY | Show WHO |
| C01A | CARDIAC GLYCOSIDES | Show WHO |
| C01AA | Digitalis glycosides | Show WHO |
| C01AA01 | Acetyldigitoxin | Show WHO |
| C01AA02 | Acetyldigoxin | Show WHO |
| C01AA03 | Digitalis leaves | Show WHO |
| C01AA04 | Digitoxin | Show WHO |
| C01AA05 | Digoxin | Show WHO |
| C01AA06 | Lanatoside C | Show WHO |
| C01AA07 | Deslanoside | Show WHO |
| C01AA08 | Metildigoxin | Show WHO |
| C01AA09 | Gitoformate | Show WHO |
| C01AA52 | Acetyldigoxin, combinations | Show WHO |
| C01AB | Scilla glycosides | Show WHO |
| C01AB01 | Proscillaridin | Show WHO |
| C01AB51 | Proscillaridin, combinations | Show WHO |
| C01AC | Strophantus glycosides | Show WHO |
| C01AC01 | G-strophanthin | Show WHO |
| C01AC03 | Cymarin | Show WHO |
| C01AX | Other cardiac glycosides | Show WHO |
| C01AX02 | Peruvoside | Show WHO |
| C01B | ANTIARRHYTHMICS, CLASS I AND III | Show WHO |
| C01BA | Antiarrhythmics, class Ia | Show WHO |
| C01BA01 | Quinidine | Show WHO |
| C01BA02 | Procainamide | Show WHO |
| C01BA03 | Disopyramide | Show WHO |
| C01BA04 | Sparteine | Show WHO |
| C01BA05 | Ajmaline | Show WHO |
| C01BA08 | Prajmaline | Show WHO |
| C01BA12 | Lorajmine | Show WHO |
| C01BA51 | Quinidine, combinations EXCLUDING psycholeptics | Show WHO |
| C01BA71 | Quinidine, combinations with psycholeptics | Show WHO |
| C01BB | Antiarrhythmics, class Ib | Show WHO |
| C01BB01 | Lidocaine | Show WHO |
| C01BB02 | Mexiletine | Show WHO |
| C01BB03 | Tocainide | Show WHO |
| C01BB04 | Aprindine | Show WHO |
| C01BC | Antiarrhythmics, class Ic | Show WHO |
| C01BC03 | Propafenone | Show WHO |
| C01BC04 | Flecainide | Show WHO |
| C01BC07 | Lorcainide | Show WHO |
| C01BC08 | Encainide | Show WHO |
| C01BD | Antiarrhythmics, class III | Show WHO |
| C01BD01 | Amiodarone | Show WHO |
| C01BD02 | Bretylium tosilate | Show WHO |
| C01BD03 | Bunaftine | Show WHO |
| C01BD04 | Dofetilide | Show WHO |
| C01BD05 | Ibutilide | Show WHO |
| C01BG | Other class I antiarrhythmics | Show WHO |
| C01BG01 | Moracizine | Show WHO |
| C01BG07 | Cibenzoline | Show WHO |
| C01C | CARDIAC STIMULANTS EXCLUDING CARDIAC GLYCOSIDES | Show WHO |
| C01CA | Adrenergic and dopaminergic agents | Show WHO |
| C01CA01 | Etilefrine | Show WHO |
| C01CA02 | Isoprenaline | Show WHO |
| C01CA03 | Norepinephrine | Show WHO |
| C01CA04 | Dopamine | Show WHO |
| C01CA05 | Norfenefrine | Show WHO |
| C01CA06 | Phenylephrine | Show WHO |
| C01CA07 | Dobutamine | Show WHO |
| C01CA08 | Oxedrine | Show WHO |
| C01CA09 | Metaraminol | Show WHO |
| C01CA10 | Methoxamine | Show WHO |
| C01CA11 | Mephentermine | Show WHO |
| C01CA12 | Dimetofrine | Show WHO |
| C01CA13 | Prenalterol | Show WHO |
| C01CA14 | Dopexamine | Show WHO |
| C01CA15 | Gepefrine | Show WHO |
| C01CA16 | Ibopamine | Show WHO |
| C01CA17 | Midodrine | Show WHO |
| C01CA18 | Octopamine | Show WHO |
| C01CA19 | Fenoldopam | Show WHO |
| C01CA21 | Cafedrine | Show WHO |
| C01CA22 | Arbutamine | Show WHO |
| C01CA23 | Theodrenaline | Show WHO |
| C01CA24 | Epinephrine | Show WHO |
| C01CA30 | Combinations | Show WHO |
| C01CA51 | Etilefrine, combinations | Show WHO |
| C01CE | Phosphodiesterase inhibitors | Show WHO |
| C01CE01 | Amrinone | Show WHO |
| C01CE02 | Milrinone | Show WHO |
| C01CE03 | Enoximone | Show WHO |
| C01CE04 | Bucladesine | Show WHO |
| C01CX | Other cardiac stimulants | Show WHO |
| C01CX06 | Angiotensinamide | Show WHO |
| C01CX07 | Xamoterol | Show WHO |
| C01CX08 | Levosimendan | Show WHO |
| C01D | VASODILATORS USED IN CARDIAC DISEASES | Show WHO |
| C01DA | Organic nitrates | Show WHO |
| C01DA02 | Glyceryl trinitrate | Show WHO |
| C01DA04 | Methylpropylpropanediol dinitrate | Show WHO |
| C01DA05 | Pentaerithrityl tetranitrate | Show WHO |
| C01DA07 | Propatylnitrate | Show WHO |
| C01DA08 | Isosorbide dinitrate | Show WHO |
| C01DA09 | Trolnitrate | Show WHO |
| C01DA13 | Eritrityl tetranitrate | Show WHO |
| C01DA14 | Isosorbide mononitrate | Show WHO |
| C01DA20 | Organic nitrates in combination | Show WHO |
| C01DA38 | Tenitramine | Show WHO |
| C01DA52 | Glyceryl trinitrate, combinations | Show WHO |
| C01DA54 | Methylpropylpropanediol dinitrate, combinations | Show WHO |
| C01DA55 | Pentaerithrityl tetranitrate, combinations | Show WHO |
| C01DA57 | Propatylnitrate, combinations | Show WHO |
| C01DA58 | Isosorbide dinitrate, combinations | Show WHO |
| C01DA59 | Trolnitrate, combinations | Show WHO |
| C01DA63 | Eritrityl tetranitrate, combinations | Show WHO |
| C01DA70 | Organic nitrates in combination with psycholeptics | Show WHO |
| C01DB | Quinolone vasodilators | Show WHO |
| C01DB01 | Flosequinan | Show WHO |
| C01DX | Other vasodilators used in cardiac diseases | Show WHO |
| C01DX01 | Itramin tosilate | Show WHO |
| C01DX02 | Prenylamine | Show WHO |
| C01DX03 | Oxyfedrine | Show WHO |
| C01DX04 | Benziodarone | Show WHO |
| C01DX05 | Carbocromen | Show WHO |
| C01DX06 | Hexobendine | Show WHO |
| C01DX07 | Etafenone | Show WHO |
| C01DX08 | Heptaminol | Show WHO |
| C01DX09 | Imolamine | Show WHO |
| C01DX10 | Dilazep | Show WHO |
| C01DX11 | Trapidil | Show WHO |
| C01DX12 | Molsidomine | Show WHO |
| C01DX13 | Efloxate | Show WHO |
| C01DX14 | Cinepazet | Show WHO |
| C01DX15 | Cloridarol | Show WHO |
| C01DX16 | Nicorandil | Show WHO |
| C01DX18 | Linsidomine | Show WHO |
| C01DX19 | Nesiritide | Show WHO |
| C01DX51 | Itramin tosilate, combinations | Show WHO |
| C01DX52 | Prenylamine, combinations | Show WHO |
| C01DX53 | Oxyfedrine, combinations | Show WHO |
| C01DX54 | Benziodarone, combinations | Show WHO |
| C01E | OTHER CARDIAC PREPARATIONS | Show WHO |
| C01EA | Prostaglandins | Show WHO |
| C01EA01 | Alprostadil | Show WHO |
| C01EB | Other cardiac preparations | Show WHO |
| C01EB02 | Camphora | Show WHO |
| C01EB03 | Indometacin | Show WHO |
| C01EB04 | Crataegus glycosides | Show WHO |
| C01EB05 | Creatinolfosfate | Show WHO |
| C01EB06 | Fosfocreatine | Show WHO |
| C01EB07 | Fructose 1,6-diphosphate | Show WHO |
| C01EB09 | Ubidecarenone | Show WHO |
| C01EB10 | Adenosine | Show WHO |
| C01EB11 | Tiracizine | Show WHO |
| C01EB12 | Tedisamil | Show WHO |
| C01EB13 | Acadesine | Show WHO |
| C01EB15 | Trimetazidine | Show WHO |
| C01EX | Other cardiac combination products | Show WHO |
| C02 | ANTIHYPERTENSIVES | Show WHO |
| C02A | ANTIADRENERGIC AGENTS, CENTRALLY ACTING | Show WHO |
| C02AA | Rauwolfia alkaloids | Show WHO |
| C02AA01 | Rescinnamine | Show WHO |
| C02AA02 | Reserpine | Show WHO |
| C02AA03 | Combinations of rauwolfia alkaloids | Show WHO |
| C02AA04 | Rauwolfia alkaloids, whole root | Show WHO |
| C02AA05 | Deserpidine | Show WHO |
| C02AA06 | Methoserpidine | Show WHO |
| C02AA07 | Bietaserpine | Show WHO |
| C02AA52 | Reserpine, combinations | Show WHO |
| C02AA53 | Combinations of rauwolfia alkoloids, combinations | Show WHO |
| C02AA57 | Bietaserpine, combinations | Show WHO |
| C02AB | Methyldopa | Show WHO |
| C02AB01 | Methyldopa (levorotatory) | Show WHO |
| C02AB02 | Methyldopa (racemic) | Show WHO |
| C02AC | Imidazoline receptor agonists | Show WHO |
| C02AC01 | Clonidine | Show WHO |
| C02AC02 | Guanfacine | Show WHO |
| C02AC04 | Tolonidine | Show WHO |
| C02AC05 | Moxonidine | Show WHO |
| C02AC06 | Rilmenidine | Show WHO |
| C02B | ANTIADRENERGIC AGENTS, GANGLION-BLOCKING | Show WHO |
| C02BA | Sulfonium derivatives | Show WHO |
| C02BA01 | Trimetaphan | Show WHO |
| C02BB | Secondary and tertiary amines | Show WHO |
| C02BB01 | Mecamylamine | Show WHO |
| C02BC | Bisquaternary ammonium compounds | Show WHO |
| C02C | ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING | Show WHO |
| C02CA | Alpha-adrenoreceptor antagonists | Show WHO |
| C02CA01 | Prazosin | Show WHO |
| C02CA02 | Indoramin | Show WHO |
| C02CA03 | Trimazosin | Show WHO |
| C02CA04 | Doxazosin | Show WHO |
| C02CA06 | Urapidil | Show WHO |
| C02CC | Guanidine derivatives | Show WHO |
| C02CC01 | Betanidine | Show WHO |
| C02CC02 | Guanethidine | Show WHO |
| C02CC03 | Guanoxan | Show WHO |
| C02CC04 | Debrisoquine | Show WHO |
| C02CC05 | Guanoclor | Show WHO |
| C02CC06 | Guanazodine | Show WHO |
| C02CC07 | Guanoxabenz | Show WHO |
| C02D | ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON | Show WHO |
| C02DA | Thiazide derivatives | Show WHO |
| C02DA01 | Diazoxide | Show WHO |
| C02DB | Hydrazinophthalazine derivatives | Show WHO |
| C02DB01 | Dihydralazine | Show WHO |
| C02DB02 | Hydralazine | Show WHO |
| C02DB03 | Endralazine | Show WHO |
| C02DB04 | Cadralazine | Show WHO |
| C02DC | Pyrimidine derivatives | Show WHO |
| C02DC01 | Minoxidil | Show WHO |
| C02DD | Nitroferricyanide derivatives | Show WHO |
| C02DD01 | Nitroprusside | Show WHO |
| C02DG | Guanidine derivatives | Show WHO |
| C02DG01 | Pinacidil | Show WHO |
| C02K | OTHER ANTIHYPERTENSIVES | Show WHO |
| C02KA | Alkaloids, EXCLUDING rauwolfia | Show WHO |
| C02KA01 | Veratrum | Show WHO |
| C02KB | Tyrosine hydroxylase inhibitors | Show WHO |
| C02KB01 | Metirosine | Show WHO |
| C02KC | MAO inhibitors | Show WHO |
| C02KC01 | Pargyline | Show WHO |
| C02KD | Serotonin antagonists | Show WHO |
| C02KD01 | Ketanserin | Show WHO |
| C02KX | Other antihypertensives | Show WHO |
| C02KX01 | Bosentan | Show WHO |
| C02L | ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION | Show WHO |
| C02LA | Rauwolfia alkaloids and diuretics in combination | Show WHO |
| C02LA01 | Reserpine and diuretics | Show WHO |
| C02LA02 | Rescinnamine and diuretics | Show WHO |
| C02LA03 | Deserpidine and diuretics | Show WHO |
| C02LA04 | Methoserpidine and diuretics | Show WHO |
| C02LA07 | Bietaserpine and diuretics | Show WHO |
| C02LA08 | Rauwolfia alkaloids, whole root and diuretics | Show WHO |
| C02LA09 | Syrosingopine and diuretics | Show WHO |
| C02LA50 | Comb. of rauwolfia alkaloids and diuretics incl. other combinations | Show WHO |
| C02LA51 | Reserpine and diuretics, combinations with other drugs | Show WHO |
| C02LA52 | Rescinnamine and diuretics, combinations with other drugs | Show WHO |
| C02LA71 | Reserpine and diuretics, combinations with psycholeptics | Show WHO |
| C02LB | Methyldopa and diuretics in combination | Show WHO |
| C02LB01 | Methyldopa (levorotatory) and diuretics | Show WHO |
| C02LC | Imidazoline receptor agonists in combination with diuretics | Show WHO |
| C02LC01 | Clonidine and diuretics | Show WHO |
| C02LC05 | Moxonidine and diuretics | Show WHO |
| C02LC51 | Clonidine and diuretics, combinations with other drugs | Show WHO |
| C02LE | Alpha-adrenoreceptor antagonists and diuretics | Show WHO |
| C02LE01 | Prazosin and diuretics | Show WHO |
| C02LF | Guanidine derivatives and diuretics | Show WHO |
| C02LF01 | Guanethidine and diuretics | Show WHO |
| C02LG | Hydrazinophthalazine derivatives and diuretics | Show WHO |
| C02LG01 | Dihydralazine and diuretics | Show WHO |
| C02LG02 | Hydralazine and diuretics | Show WHO |
| C02LG03 | Picodralazine and diuretics | Show WHO |
| C02LG51 | Dihydralazine and diuretics, combinations with other drugs | Show WHO |
| C02LG73 | Picodralazine and diuretics, combinations with psycholeptics | Show WHO |
| C02LK | Alkaloids, EXCLUDING rauwolfia, in combination with diuretics | Show WHO |
| C02LK01 | Veratrum and diuretics | Show WHO |
| C02LL | MAO inhibitors and diuretics | Show WHO |
| C02LL01 | Pargyline and diuretics | Show WHO |
| C02LN | Serotonin antagonists and diuretics | Show WHO |
| C02LX | Other antihypertensives and diuretics | Show WHO |
| C02LX01 | Pinacidil and diuretics | Show WHO |
| C02N | COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 | Show WHO |
| C03 | DIURETICS | Show WHO |
| C03A | LOW-CEILING DIURETICS, THIAZIDES | Show WHO |
| C03AA | Thiazides, plain | Show WHO |
| C03AA01 | Bendroflumethiazide | Show WHO |
| C03AA02 | Hydroflumethiazide | Show WHO |
| C03AA03 | Hydrochlorothiazide | Show WHO |
| C03AA04 | Chlorothiazide | Show WHO |
| C03AA05 | Polythiazide | Show WHO |
| C03AA06 | Trichlormethiazide | Show WHO |
| C03AA07 | Cyclopenthiazide | Show WHO |
| C03AA08 | Methyclothiazide | Show WHO |
| C03AA09 | Cyclothiazide | Show WHO |
| C03AA13 | Mebutizide | Show WHO |
| C03AB | Thiazides and potassium in combination | Show WHO |
| C03AB01 | Bendroflumethiazide and potassium | Show WHO |
| C03AB02 | Hydroflumethiazide and potassium | Show WHO |
| C03AB03 | Hydrochlorothiazide and potassium | Show WHO |
| C03AB04 | Chlorothiazide and potassium | Show WHO |
| C03AB05 | Polythiazide and potassium | Show WHO |
| C03AB06 | Trichlormethiazide and potassium | Show WHO |
| C03AB07 | Cyclopenthiazide and potassium | Show WHO |
| C03AB08 | Methyclothiazide and potassium | Show WHO |
| C03AB09 | Cyclothiazide and potassium | Show WHO |
| C03AH | Thiazides, combinations with psycholeptics and/or analgesics | Show WHO |
| C03AH01 | Chlorothiazide, combinations | Show WHO |
| C03AH02 | Hydroflumethiazide, combinations | Show WHO |
| C03AX | Thiazides, combinations with other drugs | Show WHO |
| C03AX01 | Hydrochlorothiazide, combinations | Show WHO |
| C03B | LOW-CEILING DIURETICS, EXCLUDING THIAZIDES | Show WHO |
| C03BA | Sulfonamides, plain | Show WHO |
| C03BA02 | Quinethazone | Show WHO |
| C03BA03 | Clopamide | Show WHO |
| C03BA04 | Chlortalidone | Show WHO |
| C03BA05 | Mefruside | Show WHO |
| C03BA07 | Clofenamide | Show WHO |
| C03BA08 | Metolazone | Show WHO |
| C03BA09 | Meticrane | Show WHO |
| C03BA10 | Xipamide | Show WHO |
| C03BA11 | Indapamide | Show WHO |
| C03BA12 | Clorexolone | Show WHO |
| C03BA13 | Fenquizone | Show WHO |
| C03BA82 | Clorexolone, comb. with psycholeptics | Show WHO |
| C03BB | Sulfonamides and potassium in combination | Show WHO |
| C03BB02 | Quinethazone and potassium | Show WHO |
| C03BB03 | Clopamide and potassium | Show WHO |
| C03BB04 | Chlortalidone and potassium | Show WHO |
| C03BB05 | Mefruside and potassium | Show WHO |
| C03BB07 | Clofenamide and potassium | Show WHO |
| C03BC | Mercurial diuretics | Show WHO |
| C03BC01 | Mersalyl | Show WHO |
| C03BD | Xanthine derivatives | Show WHO |
| C03BD01 | Theobromine | Show WHO |
| C03BK | Sulfonamides, combinations with other drugs | Show WHO |
| C03BX | Other low-ceiling diuretics | Show WHO |
| C03BX03 | Cicletanine | Show WHO |
| C03C | HIGH-CEILING DIURETICS | Show WHO |
| C03CA | Sulfonamides, plain | Show WHO |
| C03CA01 | Furosemide | Show WHO |
| C03CA02 | Bumetanide | Show WHO |
| C03CA03 | Piretanide | Show WHO |
| C03CA04 | Torasemide | Show WHO |
| C03CB | Sulfonamides and potassium in combination | Show WHO |
| C03CB01 | Furosemide and potassium | Show WHO |
| C03CB02 | Bumetanide and potassium | Show WHO |
| C03CC | Aryloxyacetic acid derivatives | Show WHO |
| C03CC01 | Etacrynic acid | Show WHO |
| C03CC02 | Tienilic acid | Show WHO |
| C03CD | Pyrazolone derivatives | Show WHO |
| C03CD01 | Muzolimine | Show WHO |
| C03CX | Other high-ceiling diuretics | Show WHO |
| C03CX01 | Etozolin | Show WHO |
| C03D | POTASSIUM-SPARING AGENTS | Show WHO |
| C03DA | Aldosterone antagonists | Show WHO |
| C03DA01 | Spironolactone | Show WHO |
| C03DA02 | Potassium canrenoate | Show WHO |
| C03DA03 | Canrenone | Show WHO |
| C03DA04 |
Eplerenone |
Show WHO |
| C03DB | Other potassium-sparing agents | Show WHO |
| C03DB01 | Amiloride | Show WHO |
| C03DB02 | Triamterene | Show WHO |
| C03E | DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION | Show WHO |
| C03EA | Low-ceiling diuretics and potassium-sparing agents | Show WHO |
| C03EA01 | Hydrochlorothiazide and potassium-sparing agents | Show WHO |
| C03EA02 | Trichlormethiazide and potassium-sparing agents | Show WHO |
| C03EA03 | Epitizide and potassium-sparing agents | Show WHO |
| C03EA04 | Altizide and potassium-sparing agents | Show WHO |
| C03EA05 | Mebutizide and potassium-sparing agents | Show WHO |
| C03EA06 | Chlortalidone and potassium-sparing agents | Show WHO |
| C03EA07 | Cyclopenthiazide and potassium-sparing agents | Show WHO |
| C03EA12 | Metolazone and potassium-sparing agents | Show WHO |
| C03EA13 | Bendroflumethiazide and potassium-sparing agents | Show WHO |
| C03EA14 | Butizide and potassium-sparing agents | Show WHO |
| C03EB | High-ceiling diuretics and potassium-sparing agents | Show WHO |
| C03EB01 | Furosemide and potassium-sparing agents | Show WHO |
| C03EB02 | Bumetanide and potassium-sparing agents | Show WHO |
| C04 | PERIPHERAL VASODILATORS | Show WHO |
| C04A | PERIPHERAL VASODILATORS | Show WHO |
| C04AA | 2-amino-1-phenylethanol derivatives | Show WHO |
| C04AA01 | Isoxsuprine | Show WHO |
| C04AA02 | Buphenine | Show WHO |
| C04AA31 | Bamethan | Show WHO |
| C04AB | Imidazoline derivatives | Show WHO |
| C04AB01 | Phentolamine | Show WHO |
| C04AB02 | Tolazoline | Show WHO |
| C04AC | Nicotinic acid and derivatives | Show WHO |
| C04AC01 | Nicotinic acid | Show WHO |
| C04AC02 | Nicotinyl alcohol (pyridylcarbinol) | Show WHO |
| C04AC03 | Inositol nicotinate | Show WHO |
| C04AC07 | Ciclonicate | Show WHO |
| C04AD | Purine derivatives | Show WHO |
| C04AD01 | Pentifylline | Show WHO |
| C04AD02 | Xantinol nicotinate | Show WHO |
| C04AD03 | Pentoxifylline | Show WHO |
| C04AD04 | Etofylline nicotinate | Show WHO |
| C04AE | Ergot alkaloids | Show WHO |
| C04AE01 | Ergoloid mesylates | Show WHO |
| C04AE02 | Nicergoline | Show WHO |
| C04AE04 | Dihydroergocristine | Show WHO |
| C04AE51 | Ergoloid mesylates, combinations | Show WHO |
| C04AE54 | Dihydroergocristine, combinations | Show WHO |
| C04AF | Enzymes | Show WHO |
| C04AF01 | Kallidinogenase | Show WHO |
| C04AX | Other peripheral vasodilators | Show WHO |
| C04AX01 | Cyclandelate | Show WHO |
| C04AX02 | Phenoxybenzamine | Show WHO |
| C04AX07 | Vincamine | Show WHO |
| C04AX10 | Moxisylyte | Show WHO |
| C04AX11 | Bencyclane | Show WHO |
| C04AX13 | Piribedil | Show WHO |
| C04AX17 | Vinburnine | Show WHO |
| C04AX19 | Sulcotidil | Show WHO |
| C04AX20 | Buflomedil | Show WHO |
| C04AX21 | Naftidrofuryl | Show WHO |
| C04AX23 | Butalamine | Show WHO |
| C04AX24 | Visnadine | Show WHO |
| C04AX26 | Cetiedil | Show WHO |
| C04AX27 | Cinepazide | Show WHO |
| C04AX28 | Ifenprodil | Show WHO |
| C04AX30 | Azapetine | Show WHO |
| C04AX32 | Fasudil | Show WHO |
| C05 | VASOPROTECTIVES | Show WHO |
| C05A | ANTIHEMORRHOIDALS FOR TOPICAL USE | Show WHO |
| C05AA | Products containing corticosteroids | Show WHO |
| C05AA01 | Hydrocortisone | Show WHO |
| C05AA04 | Prednisolone | Show WHO |
| C05AA05 | Betamethasone | Show WHO |
| C05AA06 | Fluorometholone | Show WHO |
| C05AA08 | Fluocortolone | Show WHO |
| C05AA09 | Dexamethasone | Show WHO |
| C05AA10 | Fluocinolone acetonide | Show WHO |
| C05AA11 | Fluocinonide | Show WHO |
| C05AB | Products containing antibiotics | Show WHO |
| C05AD | Products containing local anesthetics | Show WHO |
| C05AD01 | Lidocaine | Show WHO |
| C05AD02 | Tetracaine | Show WHO |
| C05AD03 | Benzocaine | Show WHO |
| C05AD04 | Cinchocaine | Show WHO |
| C05AD05 | Procaine | Show WHO |
| C05AD06 | Oxetacaine | Show WHO |
| C05AD07 | Pramocaine | Show WHO |
| C05AX | Other antihemorrhoidals for topical use | Show WHO |
| C05AX01 | Aluminium preparations | Show WHO |
| C05AX02 | Bismuth preparations, combinations | Show WHO |
| C05AX03 | Other preparations, combinations | Show WHO |
| C05AX04 | Zinc preparations | Show WHO |
| C05AX05 | Tribenoside | Show WHO |
| C05B | ANTIVARICOSE THERAPY | Show WHO |
| C05BA | Heparins or heparinoids for topical use | Show WHO |
| C05BA01 | Organo-heparinoid | Show WHO |
| C05BA02 | Sodium apolate | Show WHO |
| C05BA03 | Heparin | Show WHO |
| C05BA04 | Pentosan polysulfate sodium | Show WHO |
| C05BA51 | Heparinoid, combinations | Show WHO |
| C05BA53 | Heparin, combinations | Show WHO |
| C05BB | Sclerosing agents for local injection | Show WHO |
| C05BB01 | Monoethanolamine oleate | Show WHO |
| C05BB02 | Polidocanol | Show WHO |
| C05BB03 | Invert sugar | Show WHO |
| C05BB04 | Sodium tetradecyl sulfate | Show WHO |
| C05BB05 | Phenol | Show WHO |
| C05BB56 | Glucose, combinations | Show WHO |
| C05BX | Other sclerosing agents | Show WHO |
| C05BX01 | Calcium dobesilate | Show WHO |
| C05BX51 | Calcium dobesilate, combinations | Show WHO |
| C05C | CAPILLARY STABILIZING AGENTS | Show WHO |
| C05CA | Bioflavonoids | Show WHO |
| C05CA01 | Rutoside | Show WHO |
| C05CA02 | Monoxerutin | Show WHO |
| C05CA03 | Diosmin | Show WHO |
| C05CA04 | Troxerutin | Show WHO |
| C05CA05 | Hidrosmin | Show WHO |
| C05CA51 | Rutoside, combinations | Show WHO |
| C05CA53 | Diosmin, combinations | Show WHO |
| C05CA54 | Troxerutin, combinations | Show WHO |
| C05CX | Other capillary stabilizing agents | Show WHO |
| C05CX01 | Tribenoside | Show WHO |
| C07 | BETA BLOCKING AGENTS | Show WHO |
| C07A | BETA BLOCKING AGENTS | Show WHO |
| C07AA | Beta blocking agents, non-selective | Show WHO |
| C07AA01 | Alprenolol | Show WHO |
| C07AA02 | Oxprenolol | Show WHO |
| C07AA03 | Pindolol | Show WHO |
| C07AA05 | Propranolol | Show WHO |
| C07AA06 | Timolol | Show WHO |
| C07AA07 | Sotalol | Show WHO |
| C07AA12 | Nadolol | Show WHO |
| C07AA14 | Mepindolol | Show WHO |
| C07AA15 | Carteolol | Show WHO |
| C07AA16 | Tertatolol | Show WHO |
| C07AA17 | Bopindolol | Show WHO |
| C07AA19 | Bupranolol | Show WHO |
| C07AA23 | Penbutolol | Show WHO |
| C07AA27 | Cloranolol | Show WHO |
| C07AA57 | Sotalol, combination packages | Show WHO |
| C07AB | Beta blocking agents, selective | Show WHO |
| C07AB01 | Practolol | Show WHO |
| C07AB02 | Metoprolol | Show WHO |
| C07AB03 | Atenolol | Show WHO |
| C07AB04 | Acebutolol | Show WHO |
| C07AB05 | Betaxolol | Show WHO |
| C07AB06 | Bevantolol | Show WHO |
| C07AB07 | Bisoprolol | Show WHO |
| C07AB08 | Celiprolol | Show WHO |
| C07AB09 | Esmolol | Show WHO |
| C07AB10 | Epanolol | Show WHO |
| C07AB11 | S-atenolol | Show WHO |
| C07AB12 | Nebivolol | Show WHO |
| C07AB13 | Talinolol | Show WHO |
| C07AB52 | Metoprolol, combination packages | Show WHO |
| C07AG | Alpha and beta blocking agents | Show WHO |
| C07AG01 | Labetalol | Show WHO |
| C07AG02 | Carvedilol | Show WHO |
| C07B | BETA BLOCKING AGENTS AND THIAZIDES | Show WHO |
| C07BA | Beta blocking agents, non-selective, and thiazides | Show WHO |
| C07BA02 | Oxprenolol and thiazides | Show WHO |
| C07BA05 | Propranolol and thiazides | Show WHO |
| C07BA06 | Timolol and thiazides | Show WHO |
| C07BA07 | Sotalol and thiazides | Show WHO |
| C07BA12 | Nadolol and thiazides | Show WHO |
| C07BA68 | Metipranolol and thiazides, combinations | Show WHO |
| C07BB | Beta blocking agents, selective, and thiazides | Show WHO |
| C07BB02 | Metoprolol and thiazides | Show WHO |
| C07BB03 | Atenolol and thiazides | Show WHO |
| C07BB04 | Acebutolol and thiazides | Show WHO |
| C07BB06 | Bevantolol and thiazides | Show WHO |
| C07BB07 | Bisoprolol and thiazides | Show WHO |
| C07BB52 | Metoprolol and thiazides, combinations | Show WHO |
| C07BG | Alpha and beta blocking agents and thiazides | Show WHO |
| C07BG01 | Labetalol and thiazides | Show WHO |
| C07C | BETA BLOCKING AGENTS AND OTHER DIURETICS | Show WHO |
| C07CA | Beta blocking agents, non-selective, and other diuretics | Show WHO |
| C07CA02 | Oxprenolol and other diuretics | Show WHO |
| C07CA03 | Pindolol and other diuretics | Show WHO |
| C07CA17 | Bopindolol and other diuretics | Show WHO |
| C07CA23 | Penbutolol and other diuretics | Show WHO |
| C07CB | Beta blocking agents, selective, and other diuretics | Show WHO |
| C07CB02 | Metoprolol and other diuretics | Show WHO |
| C07CB03 | Atenolol and other diuretics | Show WHO |
| C07CB53 | Atenolol and other diuretics, combinations | Show WHO |
| C07CG | Alpha and beta blocking agents and other diuretics | Show WHO |
| C07CG01 | Labetalol and other diuretics | Show WHO |
| C07D | BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS | Show WHO |
| C07DA | Beta blocking agents, non-selective, thiazides and other diuretics | Show WHO |
| C07DA06 | Timolol, thiazides and other diuretics | Show WHO |
| C07DB | Beta blocking agents, selective, thiazides and other diuretics | Show WHO |
| C07DB01 | Atenolol, thiazides and other diuretics | Show WHO |
| C07E | BETA BLOCKING AGENTS AND VASODILATORS | Show WHO |
| C07EA | Beta blocking agents, non-selective, and vasodilators | Show WHO |
| C07EB | Beta blocking agents, selective, and vasodilators | Show WHO |
| C07F | BETA BLOCKING AGENTS AND OTHER ANTIHYPERTENSIVES | Show WHO |
| C07FA | Beta blocking agents, non-selective, and other antihypertensives | Show WHO |
| C07FA05 | Propranolol and other antihypertensives | Show WHO |
| C07FB | Beta blocking agents, selective, and other antihypertensives | Show WHO |
| C07FB02 | Metoprolol and other antihypertensives | Show WHO |
| C07FB03 | Atenolol and other antihypertensives | Show WHO |
| C08 | CALCIUM CHANNEL BLOCKERS | Show WHO |
| C08C | SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS | Show WHO |
| C08CA | Dihydropyridine derivatives | Show WHO |
| C08CA01 | Amlodipine | Show WHO |
| C08CA02 | Felodipine | Show WHO |
| C08CA03 | Isradipine | Show WHO |
| C08CA04 | Nicardipine | Show WHO |
| C08CA05 | Nifedipine | Show WHO |
| C08CA06 | Nimodipine | Show WHO |
| C08CA07 | Nisoldipine | Show WHO |
| C08CA08 | Nitrendipine | Show WHO |
| C08CA09 | Lacidipine | Show WHO |
| C08CA10 | Nilvadipine | Show WHO |
| C08CA11 | Manidipine | Show WHO |
| C08CA12 | Barnidipine | Show WHO |
| C08CA13 | Lercanidipine | Show WHO |
| C08CA14 | Cilnidipine | Show WHO |
| C08CA15 | Benidipine | Show WHO |
| C08CA55 | Nifedipine, combinations | Show WHO |
| C08CX | Other selective calcium channel blockers with mainly vascular effects | Show WHO |
| C08CX01 | Mibefradil | Show WHO |
| C08D | SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS | Show WHO |
| C08DA | Phenylalkylamine derivatives | Show WHO |
| C08DA01 | Verapamil | Show WHO |
| C08DA02 | Gallopamil | Show WHO |
| C08DA51 | Verapamil, combinations | Show WHO |
| C08DB | Benzothiazepine derivatives | Show WHO |
| C08DB01 | Diltiazem | Show WHO |
| C08E | NON-SELECTIVE CALCIUM CHANNEL BLOCKERS | Show WHO |
| C08EA | Phenylalkylamine derivatives | Show WHO |
| C08EA01 | Fendiline | Show WHO |
| C08EA02 | Bepridil | Show WHO |
| C08EX | Other non-selective calcium channel blockers | Show WHO |
| C08EX01 | Lidoflazine | Show WHO |
| C08EX02 | Perhexiline | Show WHO |
| C08G | CALCIUM CHANNEL BLOCKERS AND DIURETICS | Show WHO |
| C08GA | Calcium channel blockers and diuretics | Show WHO |
| C08GA01 | Nifedipine and diuretics | Show WHO |
| C09 | AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM | Show WHO |
| C09A | ACE INHIBITORS, PLAIN | Show WHO |
| C09AA | ACE inhibitors, plain | Show WHO |
| C09AA01 | Captopril | Show WHO |
| C09AA02 | Enalapril | Show WHO |
| C09AA03 | Lisinopril | Show WHO |
| C09AA04 | Perindopril | Show WHO |
| C09AA05 | Ramipril | Show WHO |
| C09AA06 | Quinapril | Show WHO |
| C09AA07 | Benazepril | Show WHO |
| C09AA08 | Cilazapril | Show WHO |
| C09AA09 | Fosinopril | Show WHO |
| C09AA10 | Trandolapril | Show WHO |
| C09AA11 | Spirapril | Show WHO |
| C09AA12 | Delapril | Show WHO |
| C09AA13 | Moexipril | Show WHO |
| C09AA14 | Temocapril | Show WHO |
| C09AA15 | Zofenopril | Show WHO |
| C09AA16 | Imidapril | Show WHO |
| C09B | ACE INHIBITORS, COMBINATIONS | Show WHO |
| C09BA | ACE inhibitors and diuretics | Show WHO |
| C09BA01 | Captopril and diuretics | Show WHO |
| C09BA02 | Enalapril and diuretics | Show WHO |
| C09BA03 | Lisinopril and diuretics | Show WHO |
| C09BA04 | Perindopril and diuretics | Show WHO |
| C09BA05 | Ramipril and diuretics | Show WHO |
| C09BA06 | Quinapril and diuretics | Show WHO |
| C09BA07 | Benazepril and diuretics | Show WHO |
| C09BA08 | Cilazapril and diuretics | Show WHO |
| C09BA09 | Fosinopril and diuretics | Show WHO |
| C09BA12 | Delapril and diuretics | Show WHO |
| C09BA13 | Moexipril and diuretics | Show WHO |
| C09BB | ACE inhibitors and calcium channel blockers | Show WHO |
| C09BB05 | Ramipril and calcium channel blockers | Show WHO |
| C09BB10 | Trandolapril and calcium channel blockers | Show WHO |
| C09BB12 | Delapril and calcium channel blockers | Show WHO |
| C09C | ANGIOTENSIN II ANTAGONISTS, PLAIN | Show WHO |
| C09CA | Angiotensin II antagonists, plain | Show WHO |
| C09CA01 | Losartan | Show WHO |
| C09CA02 | Eprosartan | Show WHO |
| C09CA03 | Valsartan | Show WHO |
| C09CA04 | Irbesartan | Show WHO |
| C09CA05 | Tasosartan | Show WHO |
| C09CA06 | Candesartan | Show WHO |
| C09CA07 | Telmisartan | Show WHO |
| C09CA08 | Olmesartan medoxomil | Show WHO |
| C09D | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS | Show WHO |
| C09DA | Angiotensin II antagonists and diuretics | Show WHO |
| C09DA01 | Losartan and diuretics | Show WHO |
| C09DA02 | Eprosartan and diuretics | Show WHO |
| C09DA03 | Valsartan and diuretics | Show WHO |
| C09DA04 | Irbesartan and diuretics | Show WHO |
| C09DA06 | Candesartan and diuretics | Show WHO |
| C09DA07 | Telmisartan and diuretics | Show WHO |
| C09DA08 | Olmesartan medoxomil and diuretics | Show WHO |
| C09DB | Angiotensin II antagonists and calcium channel blockers | Show WHO |
| C09DB01 | Valsartan and amlodipine | Show WHO |
| C09DB02 | olmesartan medoxomil and amlodipine | Show WHO |
| C09X | OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM | Show WHO |
| C09XA | Renin-inhibitors | Show WHO |
| C09XA01 | remikiren | Show WHO |
| C09XA02 | aliskiren | Show WHO |
| C09XA52 | aliskiren and hydrochlorothiazide | Show WHO |
| C10 | SERUM LIPID REDUCING AGENTS | Show WHO |
| C10A | CHOLESTEROL AND TRIGLYCERIDE REDUCERS | Show WHO |
| C10AA | HMG CoA reductase inhibitors | Show WHO |
| C10AA01 | Simvastatin | Show WHO |
| C10AA02 | Lovastatin | Show WHO |
| C10AA03 | Pravastatin | Show WHO |
| C10AA04 | Fluvastatin | Show WHO |
| C10AA05 | Atorvastatin | Show WHO |
| C10AA06 | Cerivastatin | Show WHO |
| C10AA07 | Rosuvastatin | Show WHO |
| C10AA08 | pitavastatin | Show WHO |
| C10AB | Fibrates | Show WHO |
| C10AB01 | Clofibrate | Show WHO |
| C10AB02 | Bezafibrate | Show WHO |
| C10AB03 | Aluminium clofibrate | Show WHO |
| C10AB04 | Gemfibrozil | Show WHO |
| C10AB05 | Fenofibrate | Show WHO |
| C10AB06 | Simfibrate | Show WHO |
| C10AB07 | Ronifibrate | Show WHO |
| C10AB08 | Ciprofibrate | Show WHO |
| C10AB09 | Etofibrate | Show WHO |
| C10AB10 | Clofibride | Show WHO |
| C10AC | Bile acid sequestrants | Show WHO |
| C10AC01 | Colestyramine | Show WHO |
| C10AC02 | Colestipol | Show WHO |
| C10AC03 | Detaxtran | Show WHO |
| C10AC04 | Colesevelam | Show WHO |
| C10AD | Nicotinic acid and derivatives | Show WHO |
| C10AD01 | Niceritrol | Show WHO |
| C10AD02 | Nicotinic acid | Show WHO |
| C10AD03 | Nicofuranose | Show WHO |
| C10AD04 | Aluminium nicotinate | Show WHO |
| C10AD05 | Nicotinyl alcohol (pyridylcarbinol) | Show WHO |
| C10AD06 | Acipimox | Show WHO |
| C10AD52 | nicotinic acid, combinations | Show WHO |
| Other cholesterol and triglyceride reducers | Show WHO | |
| C10AX01 | Dextrothyroxine | Show WHO |
| C10AX02 | Probucol | Show WHO |
| C10AX03 | Tiadenol | Show WHO |
| C10AX04 | Benfluorex | Show WHO |
| C10AX05 | Meglutol | Show WHO |
| C10AX06 | Omega-3-triglycerides | Show WHO |
| C10AX07 | Magnesium pyridoxal 5-phosphate glutamate | Show WHO |
| C10AX08 | Policosanol | Show WHO |
| C10AX09 | Ezetimibe | Show WHO |
| C10AX10 | alipogene tiparvovec | Show WHO |
| C10B | LIPID MODIFYING AGENTS, COMBINATIONS | Show WHO |
| C10BA | HMG CoA reductase inhibitors in combination with other lipid modifying agents | Show WHO |
| C10BA01 | lovastatin and nicotinic acid | Show WHO |
| C10BA02 | simvastatin and ezetimibe | Show WHO |
| C10BA03 | pravastatin and fenofibrate | Show WHO |
| C10BX | HMG CoA reductase inhibitors, other combinations | Show WHO |
| C10BX01 | simvastatin and acetylsalicylic acid | Show WHO |
| C10BX02 | pravastatin and acetylsalicylic acid | Show WHO |
| C10BX03 | atorvastatin and amlodipine | Show WHO |
|
|
|||||||||||||||
|
|
C |
|
|||||||||||||
|
|
|||||||||||||||